SEC Form 4 · accession 0001209191-16-141585
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Papanek
Director
Period of report
Sep 13, 2016
Accepted (ET)
Sep 15, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $12.88 | Sep 13, 2016 | A | 24,000 | A | — | Sep 13, 2026 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest in equal monthly installments over a three-year period from the vesting commencement date of August 10, 2016.